Compagnie Lombard Odier SCmA’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-850
| Closed | -$10.8K | – | 491 |
|
|
2024
Q2 | $10.8K | Sell |
850
-1,750
| -67% | -$22.2K | ﹤0.01% | 393 |
|
|
2024
Q1 | $12.4K | Sell |
2,600
-988
| -28% | -$4.72K | ﹤0.01% | 417 |
|
|
2023
Q4 | $17.2K | Hold |
3,588
| – | – | ﹤0.01% | 468 |
|
|
2023
Q3 | $26K | Sell |
3,588
-1,998
| -36% | -$14.5K | ﹤0.01% | 474 |
|
|
2023
Q2 | $41.5K | Hold |
5,586
| – | – | ﹤0.01% | 425 |
|
|
2023
Q1 | $38.7K | Hold |
5,586
| – | – | ﹤0.01% | 468 |
|
|
2022
Q4 | $56K | Buy |
5,586
+2,886
| +107% | +$28.9K | ﹤0.01% | 462 |
|
|
2022
Q3 | $49K | Hold |
2,700
| – | – | ﹤0.01% | 458 |
|
|
2022
Q2 | $138K | Hold |
2,700
| – | – | ﹤0.01% | 342 |
|
|
2022
Q1 | $198K | Buy |
2,700
+920
| +52% | +$67.5K | ﹤0.01% | 307 |
|
|
2021
Q4 | $255K | Buy |
1,780
+600
| +51% | +$86K | 0.01% | 325 |
|
|
2021
Q3 | $245K | Buy |
1,180
+130
| +12% | +$27K | 0.01% | 327 |
|
|
2021
Q2 | $223K | Sell |
1,050
-65,852
| -98% | -$14M | ﹤0.01% | 330 |
|
|
2021
Q1 | $12.1M | Buy |
+66,902
| New | +$12.1M | 0.27% | 76 |
|
|
2020
Q4 | – | Sell |
-600
| Closed | -$65K | – | 600 |
|
|
2020
Q3 | $65K | Buy |
+600
| New | +$65K | ﹤0.01% | 360 |
|
|
2016
Q3 | – | Sell |
-700
| Closed | -$102K | – | 911 |
|
|
2016
Q2 | $102K | Buy |
+700
| New | +$102K | ﹤0.01% | 561 |
|